Table 1.
Correlation between expression of circ_0078767, miR‐330‐3p, RASSF1A and clinic pathological features in GC patients
| Parameters | Group | Total | RASSF1A | miR‐330‐3p | circ_0078767 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Low | High | P | Low | High | P | Low | High | P | |||
| Gender | Male | 12 | 3 | 9 | 0.356 | 7 | 5 | 0.650 | 7 | 5 | 0.642 |
| Female | 8 | 4 | 4 | 3 | 5 | 6 | 2 | ||||
| Age | <60 | 6 | 3 | 3 | 0.613 | 2 | 4 | 0.629 | 5 | 1 | 0.354 |
| ≥60 | 14 | 4 | 10 | 8 | 6 | 8 | 6 | ||||
| Tumour size | <3 cm | 5 | 4 | 1 | 0.037* | 1 | 4 | 0.303 | 1 | 4 | 0.031* |
| ≥3 cm | 15 | 3 | 12 | 9 | 6 | 12 | 3 | ||||
| Differentiation | Well | 8 | 4 | 4 | 0.356 | 3 | 5 | 0.650 | 6 | 2 | 0.642 |
| Moderate/Poor | 12 | 3 | 9 | 7 | 5 | 7 | 5 | ||||
| TNM stage | I + II | 10 | 6 | 7 | 0.057 | 2 | 8 | 0.023* | 9 | 1 | 0.057 |
| III + IV | 10 | 1 | 3 | 8 | 2 | 4 | 6 | ||||
| Lymph node metastasis | Absence | 9 | 6 | 3 | 0.017* | 8 | 1 | 0.005* | 3 | 6 | 0.017* |
| Presence | 11 | 1 | 10 | 2 | 9 | 10 | 1 | ||||
Low and High expression group were divided according to the median ratio of relative RNA expression.
*P value was determined by chi‐square analysis. P ＜ 0.05 was statistically significant.